Metraipolis › archive › dc_ee8a657e5187
Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42495484
- DOI
- 10.7759/cureus.111363
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T06:07:43.469Z
- SHA-256 of the archived text
5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65- Stable URL of this page
https://metraipolis.com/documento/dc_ee8a657e5187
How to cite
Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484 — Europe PMC (en), https://europepmc.org/article/MED/42495484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee8a657e5187 (Metraipolis archive dc_ee8a657e5187, sha256 5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65)
BibTeX
@misc{dcee8a657e5187,
title = {Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42495484},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee8a657e5187; sha256 5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42495484. Agents can read the archived copy with the MCP tool read_document.